Company Search:
Advanced Search
Sponsored Links
bioasis Technologies Inc. Company Snapshot
bioasis Technologies Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares bioasis Technologies Inc. with three other miscellaneous service companies in North America: Revance Therapeutics Inc of the United States (2016 sales of $300,000.00 of which 100% was Botulinum Toxin Products), Proteo, Inc. of the United States ($242,930.00 ), and Dicerna Pharmaceuticals Inc which is also based in the United States ($295,000.00 of which 100% was RNA Interference (RNAi) Therapeutics).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
bioasis Technologies Inc.
  Stock Performance Chart for bioasis Technologies Inc.
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): .83
(Figures in Canadian Dollars)
1 Week -1.2%   13 Weeks 0.0%  
4 Weeks -13.5%   52 Weeks -37.6%  
bioasis Technologies Inc. Key Data:
  Ticker: BTI Country: Canada
  Exchanges: TOR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 369,124
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 37,893,033
  Fiscal Yr Ends: February Shares Outstanding: 45,654,257
  Share Type: Closely Held Shares: 10,610,430
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.